Biological Dynamics announced it has named Kevin Han as its new Chief Financial Officer, bringing a depth of expertise in capital markets and investor relations and a breadth of healthcare industry knowledge. Mr. Han, a veteran life science industry investor, joins Biological Dynamics following an accomplished career in equity research, investment management, and investor relations, specifically focused on the life science tools, diagnostics, and medical technology sectors.